[Lab] Homopeptide survo — Medutest came back 98.4% against a claimed 98.0%
Homopeptide survo — Medutest came back 98.4% against a claimed 98.0%. One vial, one service, one member paying, which is the only kind of result this board should treat as evidence. The relevant figures are 98.4% and 98.0%, and they come from the same log I have kept the whole time. Sent a vial to PeptideMeter…
It is a dual agonist at the GLP-1 and glucagon receptors. The glucagon arm is associated with increased energy expenditure and with effects on hepatic fat, which is why the development programme is oriented towards liver disease.
Nothing containing this compound is approved anywhere. Research-use-only material is not approved for human use.
That is an escalation schedule for an unapproved compound and this board does not host those.
Yes — histological endpoints are a far harder bar than the surrogate measures people are used to quoting.
Same. Very thin independent data on this one, which should make everybody here more tentative than they are.
read the histology endpoint definitions before quoting a response rate
That figure is from the obesity programme, and this thread is about the hepatic one.
Push back: the evidence here is phase 2, in a specific population, and it does not support a general ranking.
not approved anywhere, and the boards forget that constantly
Disagree — that is a weight endpoint from a different programme and you are quoting it in a hepatic context.